pain~|~histidine~|~cardiac arrhythmia~|~akr1b10 gene~|~address type - office~|~adverse event associated with cardiac arrhythmia~|~bmp2k gene~|~bicycle~|~bicycling (recreational activity)~|~histidine measurement~|~not otherwise specified~|~off~|~office~|~organization unit type - office~|~specific qualifier value~|~structure of hippocampal fissure~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~specified time~|~usual severity pain
dyspnea~|~chest pain~|~tunica media~|~communications media~|~cdisc sdtm adverse event outcome terminology~|~check~|~checking (action)~|~hanging~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~media layer~|~out (direction)~|~pams media~|~removed~|~result~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~tcf23 gene~|~usual severity shortness of breath~|~znf699 gene~|~chest pain:finding:point in time:^patient:ordinal
communicable diseases~|~mental recall~|~canada~|~nup214 protein, human~|~not otherwise specified~|~andorra~|~and~|~and - dosing instruction fragment~|~best1 gene~|~crouzon syndrome with acanthosis nigricans (disorder)~|~can - object~|~can dosing unit~|~chronic rejection of renal transplant~|~gdc ajcc clinical n terminology~|~infectious disease pathway~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~nr4a2 gene~|~nup214 gene~|~nup214 wt allele~|~negation~|~purchase~|~relationshipconjunction - and~|~senior - suffix~|~specific qualifier value~|~best (quality)~|~blood products laboratory testing~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
light~|~pain~|~nausea~|~light cycle~|~tnfsf14 protein, human~|~best1 gene~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~in urine~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~purchase~|~specific qualifier value~|~usual severity nausea~|~best (quality)~|~acute pain due to trauma~|~administration method - pain~|~adverse event associated with pain~|~borg scale rating of perceived exertion score 11~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~light (qualifier)~|~light - subjective measurement~|~light color~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~tnfsf14 gene~|~tnfsf14 wt allele~|~usual severity pain
pregnancy in adolescence~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~generalized abdominal pain~|~time~|~best1 gene~|~during~|~during - dosing instruction fragment~|~fighting~|~infection~|~infections of musculoskeletal system~|~infections:-:point in time:^patient:-~|~not otherwise specified~|~purchase~|~ridging~|~this (eukaryote)~|~tract~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~best (quality)~|~crest - location~|~data types - time~|~generalized aches and pains~|~time (foundation metadata concept)~|~value type - time
positron-emission tomography~|~tomography, emission-computed~|~cardiac arrhythmia~|~adverse event associated with cardiac arrhythmia~|~best1 gene~|~cde protocol-cyclophosphamide/doxorubicin/etoposide~|~chia gene~|~consolidated health informatics~|~greek letter chi~|~month of may~|~purchase~|~relations~|~relative (related person)~|~salvia hispanica seed~|~specific qualifier value~|~sylvia~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~best (quality)~|~80th~|~pet animal
andorra~|~syndrome~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~motion~|~adverse event associated with syndromes~|~candy dosage form~|~generalized~|~geographic state~|~good~|~microplate well~|~nr4a2 gene~|~negation~|~specific qualifier value~|~state~|~state ownership~|~sugar candy~|~us state~|~units of measure - siemens~|~unknown (origin) (qualifier value)~|~web site~|~well~|~well marginated nodule~|~sweet flavor~|~sweet taste perception~|~nation
menogaril~|~multiple endocrine neoplasia~|~andorra~|~hospice care~|~name~|~asians~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~biological factors~|~buying drugs~|~determined by~|~ell gene~|~ell wt allele~|~ear, nose and throat~|~ear, nose and throat surgery~|~entitic~|~fighting~|~herero language~|~male population group~|~medical~|~medical referral type~|~medical school type~|~medical service~|~mende language~|~nt5e gene~|~nt5e wt allele~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~physical aggression~|~status~|~structure of entorhinal cortex~|~suicidal~|~what subject filter - status~|~hospice environment~|~dioscorea trifida~|~mdf attribute type - name~|~name (property) (qualifier value)~|~name:patient number:point in time:^patient:nominal~|~person name~|~rnf31 gene
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~canis familiaris~|~bcr protein, human~|~disease~|~howling~|~all~|~bcr gene~|~bcr wt allele~|~dog antigen~|~dog family~|~hope (emotion)~|~member organization~|~role class - member~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~member~|~definitely related to intervention~|~relate - vinyl resin~|~related personal status~|~relationships~|~role link type - related
hospice care~|~leg~|~lower extremity~|~best1 gene~|~purchase~|~best (quality)~|~entire lower leg, from knee to ankle~|~entire lower limb~|~fighting~|~nr4a2 gene~|~negation~|~side~|~this (eukaryote)~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~hospice environment~|~ipss risk category low~|~ipss-r risk category low~|~low - messagewaitingpriority~|~low - observation~|~low level~|~low mitosis-karyorrhexis index~|~value below reference range~|~low~|~low confidentiality~|~low exposure
helium~|~hospice care~|~pneumonia~|~negative surgical margin~|~adult~|~cytip gene~|~alignment~|~best1 gene~|~cdisc sdtm adverse event outcome terminology~|~clear~|~east~|~epidermal cgvhd score 0~|~fighting~|~in addition to~|~off~|~organism~|~out (direction)~|~purchase~|~remote control command - clear~|~removed~|~result~|~tcf23 gene~|~this (eukaryote)~|~with - dosing instruction fragment~|~best (quality)~|~hospice environment~|~abnormally high~|~high~|~high (finding)~|~high level~|~high mitosis-karyorrhexis index~|~ipss risk category high~|~ipss-r risk category high~|~legal adult~|~message waiting priority - high~|~observation value - high~|~open~|~open surgical procedure~|~value above reference range~|~high - actexposurelevelcode
s-adenosylmethionine~|~united arab emirates~|~major depressive disorder~|~nausea~|~unipolar depression~|~androgen response element~|~best1 gene~|~bothered by nausea~|~emotional well-being~|~emotional state observations~|~emotional states~|~feel nausea~|~feeling suicidal (finding)~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~lawyer (occupation)~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~purchase~|~same~|~study subject enrolled~|~suicidal ideation, ctcae~|~suicidal ideation:find:pt:^patient:nom~|~usual severity nausea~|~are unit of measure~|~best (quality)~|~same - roleclassontological
carbon monoxide~|~5-methoxy-n,n-diisopropyltryptamine~|~6-fluoro-6-desoxyoxymorphone~|~nausea~|~patient monitoring~|~attending (action)~|~best1 gene~|~bothered by nausea~|~carbon monoxide measurement~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~in addition to~|~louisiana (geographic location)~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~purchase~|~retained~|~track (course)~|~usual severity nausea~|~with - dosing instruction fragment~|~best (quality)~|~monitor device~|~monitor brand of insecticide~|~monitor, occupation~|~monitoring device~|~preventive monitoring
diabetes mellitus~|~proline~|~hyperglycemia~|~needs~|~patient reported outcome~|~preolivary nucleus~|~best1 gene~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~in addition to~|~patient need for (contextual qualifier)~|~proline measurement~|~purchase~|~with - dosing instruction fragment~|~best (quality)
bad protein~|~human body~|~craniocerebral trauma~|~hhip protein, human~|~rpl29 protein, human~|~st13 protein, human~|~space (astronomy)~|~ankle injuries~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~hand injuries~|~time~|~adult human body~|~bad gene~|~best1 gene~|~bad~|~before~|~body of stomach~|~body structure~|~bone structure of ischium~|~brachial amyotrophic diplegia~|~cdisc sdtm adverse event outcome terminology~|~document body~|~hhip gene~|~hhip wt allele~|~have~|~hip structure~|~human body structure~|~injury of lower leg~|~out (direction)~|~possess~|~prior medication usage~|~reg3a gene~|~reg3a wt allele~|~rpl29 gene~|~rpl29 wt allele~|~removed~|~rent~|~replaced by~|~result~|~st13 gene~|~st13 wt allele~|~space - property~|~structure of habenulopeduncular tract~|~tcf23 gene~|~this (eukaryote)~|~to specify~|~whole body~|~best (quality)~|~heme iron polypeptide~|~living expense <rent>~|~data types - time~|~time (foundation metadata concept)~|~value type - time
ask protein, human~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~best1 gene~|~dbf4 gene~|~dbf4 wt allele~|~purchase~|~best (quality)
apnea~|~apnea, ctcae~|~best1 gene~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~purchase~|~best (quality)
andorra~|~hac protocol~|~irritable mood~|~space (astronomy)~|~ankle injuries~|~foot injuries~|~and~|~and - dosing instruction fragment~|~best1 gene~|~purchase~|~relationshipconjunction - and~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~best (quality)~|~head~|~approximate~|~entire head~|~hadh gene~|~have~|~head - component of device~|~home environment~|~house (environment)~|~injury of lower leg~|~irritability, ctcae~|~irritation - emotion~|~space - property~|~specific qualifier value~|~web site~|~angular~|~internal~|~within
best1 gene~|~purchase~|~best (quality)
hyperglycemia~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae
cerebral hemorrhage~|~unconscious state~|~family~|~needs~|~andorra~|~best1 gene~|~best (quality)~|~address type - home~|~address type - office~|~and~|~and - dosing instruction fragment~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~dcstamp gene~|~decision~|~early complication of trauma~|~encounter~|~entity name part type - family~|~fighting~|~finding~|~healthcare encounter~|~herero language~|~home environment~|~interested~|~intracranial injury~|~last name~|~mount device~|~mount used~|~mounts~|~nr4a2 gene~|~negation~|~not otherwise specified~|~office~|~organization unit type - home~|~organization unit type - office~|~patient visit~|~patient need for (contextual qualifier)~|~person location type - home~|~purchase~|~relationshipconjunction - and~|~team~|~this (eukaryote)~|~visit~|~visit user code - home~|~without~|~home health encounter~|~member~|~romantic~|~cerebral hemisphere hemorrhage~|~coverage level - family~|~family (taxonomic)~|~family collection~|~living arrangement - family
alcoholic intoxication, chronic~|~bad protein~|~world health organization~|~chest pain~|~nausea~|~role~|~vomiting~|~this (eukaryote)~|~bad gene~|~bad~|~billy~|~bothered by nausea~|~brachial amyotrophic diplegia~|~feel nausea~|~fighting~|~generic role~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~in addition to~|~nci thesaurus role~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~security role object~|~social role~|~terminology role entity~|~usual severity nausea~|~who temperature/humidity storage condition~|~with - dosing instruction fragment~|~role - roleclass~|~bothered by vomiting~|~chest pain:finding:point in time:^patient:ordinal~|~fine - adjective~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~legal fine~|~usual severity vomiting~|~vomiting, ctcae
pain~|~amount class - amount~|~quantity~|~specific qualifier value~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
seizures~|~alcohol consumption~|~membrane~|~approximate~|~membrane device~|~premature chromatid separation trait~|~photon correlation spectroscopy~|~tissue membrane~|~paracentral sulcus (human only)~|~nadia - zebrafish
abdominal pain~|~hyperglycemia~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~abdominal pain, ctcae 5~|~generalized abdominal pain~|~generalized aches and pains
world health organization~|~specific qualifier value~|~uncle~|~who temperature/humidity storage condition~|~year
bad protein~|~hospice care~|~ankle~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~address type - office~|~ankle joint structure~|~bad gene~|~best1 gene~|~bad~|~brachial amyotrophic diplegia~|~entire ankle region~|~farming environment~|~geographic state~|~office~|~organization unit type - office~|~purchase~|~state~|~state ownership~|~us state~|~best (quality)~|~hospice environment~|~arm pain~|~fine - adjective~|~legal fine
back pain~|~set protein, human~|~set (psychology)~|~best1 gene~|~purchase~|~best (quality)~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~acute asthma~|~antenna device~|~gas station~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~data type - any - set~|~parameterized data type - set~|~reading (activity)~|~reading (datum presentation)~|~reading ability question~|~set gene~|~set scale~|~set (group)
mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified
urinary tract infection~|~cutaneous fistula~|~communicable diseases~|~canada~|~nup214 protein, human~|~asians~|~best1 gene~|~purchase~|~best (quality)~|~adverse event associated with infection~|~crouzon syndrome with acanthosis nigricans (disorder)~|~can - object~|~can dosing unit~|~choose (action)~|~chronic rejection of renal transplant~|~favorable~|~gdc ajcc clinical n terminology~|~infection~|~international metastatic renal cell carcinoma database consortium (imdc) criteria - favorable-risk group~|~nr4a2 gene~|~nup214 gene~|~nup214 wt allele~|~nasal sinus~|~negation~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~recurrent urinary tract infection~|~signature~|~sinus - general anatomical term~|~specific qualifier value~|~tract~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~urinary tract infection, ctcae~|~pathologic fistula~|~signed - participationsignature~|~blood products laboratory testing~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
menogaril~|~multiple endocrine neoplasia~|~canada~|~nup214 protein, human~|~nausea~|~asians~|~vomiting~|~fine - adjective~|~legal fine~|~mentors~|~bothered by nausea~|~crouzon syndrome with acanthosis nigricans (disorder)~|~can - object~|~can dosing unit~|~chronic rejection of renal transplant~|~ell gene~|~ell wt allele~|~feel nausea~|~gdc ajcc clinical n terminology~|~have~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~male population group~|~mende language~|~nup214 gene~|~nup214 wt allele~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~pending - allergy clinical status~|~pending - day type~|~pending - referral status~|~pending - status~|~usual severity nausea~|~pending - managedparticipationstatus~|~pending - rolestatus~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~medical certificate~|~usual severity vomiting~|~vomiting, ctcae
muscle rigidity~|~abdominal pain~|~constipation~|~intestinal obstruction~|~abdomen~|~constipation, ctcae~|~generalized~|~have constipation~|~how much distress constipation~|~how often constipation~|~in addition to~|~not otherwise specified~|~rigid behavior~|~rigid or stiff medical device material~|~usual severity constipation~|~with - dosing instruction fragment~|~abdominal (qualifier value)~|~generalized aches and pains~|~sandia race
not otherwise specified
death domain~|~adverse event associated with death~|~amended~|~cessation of life~|~death (finding)~|~event consequence - death~|~have~|~not otherwise specified
health status~|~united arab emirates~|~paint~|~androgen response element~|~off~|~specific qualifier value~|~are unit of measure~|~left~|~left sided~|~table cell horizontal align - left
united arab emirates~|~feelings~|~hac protocol~|~back~|~cardiac arrest~|~course~|~how often felt normal question~|~normal~|~normal gait~|~normal immune presence~|~normal observation interpretation~|~normal reference range~|~normal assessment finding~|~normal, unit of concentration~|~skin appearance normal (finding)~|~normal act status~|~normal confidentiality~|~normal device alert level~|~normal entity status~|~normal managed participation status~|~normal role status~|~androgen response element~|~aspects of mortality statistics~|~back structure, excluding neck~|~back structure, including back of neck~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~cardiac arrest, ctcae 5~|~dcstamp gene~|~decision~|~dorsal~|~entire back (surface region)~|~finding~|~hadh gene~|~have~|~mortality vital statistics~|~nothing~|~periodic~|~periodic report~|~side~|~specimen source codes - respiratory~|~are unit of measure~|~respiratory
not otherwise specified
specific qualifier value~|~hypertension, ctcae~|~hypertensive disease~|~hypothermia (central) (local)~|~hypothermia due to exposure~|~hypothermia, ctcae~|~hypothermia, natural~|~shark - fish~|~shark - food~|~shark antigen~|~shark preparation
classification~|~offspring~|~gjb2 wt allele~|~have~|~kif22 gene~|~nr4a2 gene~|~negation
hospice care~|~chest pain~|~shoulder~|~andorra~|~relationshipconjunction - and~|~and~|~and - dosing instruction fragment~|~entire shoulder region~|~sentence~|~side~|~hospice environment~|~chest pain:finding:point in time:^patient:ordinal~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~general medical service~|~generalized~|~hanging~|~hypertensive disease~|~safety reporting documentation~|~united states military commissioned officer o10
microtubule-associated proteins~|~map~|~respiration disorders~|~does suck~|~sucking~|~address type - office~|~breath~|~office~|~organization unit type - office~|~respiratory tract diseases~|~suck - dosing instruction imperative~|~sucking method of administration~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~functional map~|~hypertensive disease~|~map regimen~|~mutyh-associate polyposis~|~mean blood pressure~|~myositis activities profile~|~sgsm3 gene~|~system support mapping~|~cisplatin/doxorubicin/mitomycin protocol~|~methionyl aminopeptidase activity
abdominal pain~|~mental recall~|~canada~|~constipation~|~nup214 protein, human~|~andorra~|~not otherwise specified~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~best1 gene~|~chl1 gene~|~crouzon syndrome with acanthosis nigricans (disorder)~|~call (instruction)~|~call - dosing instruction fragment~|~can - object~|~can dosing unit~|~chronic rejection of renal transplant~|~constipation, ctcae~|~decision~|~gdc ajcc clinical n terminology~|~have constipation~|~how much distress constipation~|~how often constipation~|~linda~|~nr4a2 gene~|~nup214 gene~|~nup214 wt allele~|~negation~|~relationshipconjunction - and~|~status~|~usual severity constipation~|~what subject filter - status~|~best (quality)~|~abdominal pain, ctcae 5~|~general medical service~|~generalized~|~nadia - zebrafish~|~safety reporting documentation~|~united states military commissioned officer o10
mental recall~|~have~|~not otherwise specified~|~god
rivers~|~communicable diseases~|~andorra~|~time~|~adverse event associated with infection~|~and~|~and - dosing instruction fragment~|~best1 gene~|~coop~|~entity~|~have~|~infection~|~not otherwise specified~|~purchase~|~relationshipconjunction - and~|~riveryuman language~|~best (quality)~|~sentiments~|~general medical service~|~generalized~|~language ability - sign~|~physical findings~|~safety reporting documentation~|~times~|~united states military commissioned officer o10
angina pectoris~|~chest pain~|~andorra~|~health~|~and~|~and - dosing instruction fragment~|~heart beat~|~not otherwise specified~|~relationshipconjunction - and~|~chest pain:finding:point in time:^patient:ordinal
radio~|~influenza~|~blood pressure~|~blood pressure determination~|~dyspnea~|~influenza virus vaccine~|~united arab emirates~|~congestive heart failure~|~deidentification~|~rest~|~influenza virus~|~orthomyxoviridae~|~manifest~|~manifestation of~|~specimen source codes - respiratory~|~respiratory~|~diagnosis~|~heart~|~androgen response element~|~congestive~|~diagnosis classification - diagnosis~|~diagnosis code~|~diagnosis study~|~diagnosis:impression/interpretation of study:point in time:^patient:nominal~|~do (activity)~|~due to~|~entire heart~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~hypertension, ctcae~|~hypertensive disease~|~in addition to~|~linda~|~nr4a2 gene~|~negation~|~not otherwise specified~|~radio communications~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~undergarment~|~usual severity shortness of breath~|~with - dosing instruction fragment~|~without~|~are unit of measure~|~diagnosis aspect~|~blood pressure finding~|~rest gene~|~systemic arterial pressure~|~site-specific telomere resolvase activity
rivers~|~hospice care~|~communicable diseases~|~andorra~|~adverse event associated with infection~|~and~|~and - dosing instruction fragment~|~environmental pool~|~ifng-as1 gene~|~infection~|~martes pennanti~|~not otherwise specified~|~pool (action)~|~relationshipconjunction - and~|~responsive~|~riveryuman language~|~sample pool~|~specific qualifier value~|~true~|~hospice environment~|~fine - adjective~|~legal fine
alcohol abuse~|~baseline dental cement~|~alcohol abuse scale (basc-2)~|~intoxication~|~this (eukaryote)~|~alert brand of caffeine~|~baseline~|~consciousness clear~|~uncle~|~baseline - tablecellverticalalign~|~green - answer to question~|~green color
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~mental orientation~|~bcr protein, human~|~epilepsy~|~andorra~|~italy~|~cdisc adas-cog - orientation summary score~|~genomic orientation~|~montreal cognitive assessment orientation test~|~orientation (spatial)~|~this (eukaryote)~|~all~|~and~|~and - dosing instruction fragment~|~bcr gene~|~bcr wt allele~|~fighting~|~not otherwise specified~|~relationshipconjunction - and~|~specific qualifier value~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~general medical service~|~generalized~|~intern~|~intrathecal route of drug administration~|~safety reporting documentation~|~united states military commissioned officer o10
angina pectoris~|~pelvic pain~|~andorra~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~cardiac pain~|~generalized abdominal pain~|~generalized aches and pains~|~pelvic pain, ctcae 5.0~|~pelvic pain female
athletics~|~eclampsia~|~foot~|~not otherwise specified~|~andorra~|~and~|~and - dosing instruction fragment~|~creek race~|~feet, unit of measurement~|~mental status change~|~muskogee language~|~relationshipconjunction - and~|~idiopathic epilepsy~|~possible~|~possible diagnosis~|~possibly related to intervention
class~|~classification~|~andorra~|~italy~|~and~|~and - dosing instruction fragment~|~fighting~|~hypertension, ctcae~|~hypertensive disease~|~kentucky (geographic area)~|~not otherwise specified~|~relationshipconjunction - and~|~this (eukaryote)~|~class (taxonomic)~|~intrathecal route of drug administration~|~kind of quantity - class~|~loinc class types~|~object class~|~taxonomic
light~|~abdominal pain~|~abdominal pain, ctcae 5
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~atrial fibrillation~|~cardiac arrhythmia~|~bcr protein, human~|~disease~|~italy~|~membrane~|~adverse event associated with cardiac arrhythmia~|~all~|~atrial fibrillation by ecg finding~|~atrial fibrillation, ctcae~|~bcr gene~|~bcr wt allele~|~butting~|~dcstamp gene~|~emotional tenderness~|~ever told you have or had atrial fibrillation:finding:point in time:^patient:ordinal~|~fibrillation~|~finding~|~home environment~|~house (environment)~|~membrane device~|~not otherwise specified~|~sore to touch~|~this (eukaryote)~|~tissue membrane~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~dominant~|~fine - adjective~|~intrathecal route of drug administration~|~legal fine
chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~cottage~|~decision~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~resf1 gene~|~specific qualifier value~|~status~|~what subject filter - status~|~fine - adjective~|~legal fine
not otherwise specified
do not~|~hanging~|~not otherwise specified~|~znf699 gene
dentist~|~italy~|~chen~|~dentist, general~|~ifng-as1 gene~|~not otherwise specified~|~son gene~|~son (person)~|~intrathecal route of drug administration
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~bread~|~dyspnea~|~chest pain~|~bcr protein, human~|~constipation~|~specific qualifier value~|~all~|~bcr gene~|~bcr wt allele~|~constipation, ctcae~|~have constipation~|~have shortness of breath question~|~home environment~|~house (environment)~|~how much distress constipation~|~how much distress shortness of breath~|~how often constipation~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~universal restriction modifier (core metadata concept)~|~usual severity constipation~|~usual severity shortness of breath~|~all - localmarkupignore~|~all - tablerules~|~fine - adjective~|~legal fine
diabetes mellitus~|~mental orientation~|~hyperglycemia~|~this (eukaryote)~|~best1 gene~|~cdisc adas-cog - orientation summary score~|~fighting~|~genomic orientation~|~genus tenia~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~in addition to~|~montreal cognitive assessment orientation test~|~not otherwise specified~|~orientation (spatial)~|~purchase~|~with - dosing instruction fragment~|~best (quality)~|~blood products laboratory testing~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)
climate~|~mental orientation~|~best1 gene~|~not otherwise specified~|~best (quality)~|~cdisc adas-cog - orientation summary score~|~changed status~|~changing~|~genomic orientation~|~have~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~montreal cognitive assessment orientation test~|~nr4a2 gene~|~negation~|~orientation (spatial)~|~purchase~|~fine - adjective~|~legal fine~|~game
nausea~|~vomiting~|~left lower quadrant pain~|~attending (action)~|~best1 gene~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~increment~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~ptpn5 gene~|~purchase~|~side~|~stair (equipment)~|~step (specific stage)~|~this (eukaryote)~|~treatment step~|~usual severity nausea~|~best (quality)~|~1 (finding)~|~bothered by vomiting~|~general medical service~|~generalized~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~one~|~right lower quadrant pain~|~safety reporting documentation~|~united states military commissioned officer o10~|~usual severity vomiting~|~vomiting, ctcae
tension~|~antenna device~|~bound (value)~|~genus: coronavirus~|~limit - amount class~|~limited (extensiveness)~|~side~|~general medical service~|~generalized~|~safety reporting documentation~|~united states military commissioned officer o10
pain~|~physicians~|~anatomic site~|~best1 gene~|~creek race~|~muskogee language~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~purchase~|~site~|~specimen source codes - site~|~study site~|~best (quality)~|~administration method - pain~|~adverse event associated with pain~|~author~|~baresthesia~|~feel pain~|~fine - adjective~|~frequency of pain question~|~have pain~|~how much distress pain~|~legal fine~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~pressure (finding)~|~pressure (property)~|~pressure - action~|~pressure- physical agent~|~usual severity pain
dizziness~|~lightheadedness~|~this (eukaryote)~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
muscle cramp~|~pain~|~human body~|~hac protocol~|~space (astronomy)~|~andorra~|~traumatic injury~|~trauma~|~adult human body~|~and~|~and - dosing instruction fragment~|~body of stomach~|~body structure~|~boston pharmaceuticals~|~camp gene~|~city of boston~|~document body~|~due to~|~hadh gene~|~have~|~human body structure~|~injury of elbow~|~relationshipconjunction - and~|~space - property~|~standard (document)~|~standard (qualifier)~|~standard drug stability study~|~standard environmental condition~|~trauma, nursing specialty~|~traumatic and/or non-traumatic injury~|~type of agreement - standard~|~whole body~|~wounds and injuries~|~trauma qualifier~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
andorra~|~diarrhea~|~chills~|~organ~|~and~|~and - dosing instruction fragment~|~in addition to~|~relationshipconjunction - and~|~with - dosing instruction fragment~|~anatomic site~|~chills, ctcae~|~diarrhea, ctcae~|~father (person)~|~father - courtesy title~|~have diarrhea~|~home environment~|~house (environment)~|~how much distress diarrhea~|~how often diarrhea~|~indirect exposure mechanism - father~|~lawyer (occupation)~|~pipe (object)~|~pipe dosing unit~|~piperine extract (standardized)~|~relationship - father~|~site~|~specimen source codes - site~|~study site~|~this (eukaryote)~|~usual severity diarrhea~|~fine - adjective~|~legal fine~|~favor
classification~|~communicable diseases~|~best1 gene~|~clea~|~good~|~infectious disease pathway~|~microplate well~|~nr4a2 gene~|~negation~|~organism~|~purchase~|~web site~|~well~|~well marginated nodule~|~best (quality)
magic~|~dyspnea~|~allergic reaction~|~allergy specialty~|~shock~|~hypersensitivity~|~address type - office~|~allergic disposition~|~allergy - charge type reason~|~anatomic site~|~best1 gene~|~fighting~|~gdc type terminology~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~office~|~organization unit type - office~|~purchase~|~response to antigens~|~sgcg gene~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~site~|~specimen source codes - site~|~study site~|~tension~|~this (eukaryote)~|~type - parameterizeddatatype~|~type - attribute~|~usual severity shortness of breath~|~best (quality)
back pain~|~nausea~|~vomiting~|~left upper quadrant pain~|~address type - office~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~office~|~organization unit type - office~|~usual severity nausea~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~bothered by vomiting~|~generalized abdominal pain~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
dyspnea~|~headache~|~back pain~|~nausea~|~andorra~|~and~|~and - dosing instruction fragment~|~best1 gene~|~bothered by nausea~|~feel nausea~|~have nausea~|~have shortness of breath question~|~headache, ctcae~|~how much distress nausea~|~how much distress shortness of breath~|~how much nausea during this period~|~how often nausea~|~how often shortness of breath~|~like~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~purchase~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity nausea~|~usual severity shortness of breath~|~best (quality)~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~extrinsic
classification~|~carpets~|~beak~|~acute - triage code~|~admission level of care code - acute~|~fenamole~|~good~|~injection of therapeutic agent~|~mark1 gene~|~mark1 wt allele~|~mia gene~|~massive~|~microplate well~|~nr4a2 gene~|~negation~|~owns own home~|~paroxysmal atrial tachycardia~|~rapid~|~shox2 gene~|~shark - fish~|~shark - food~|~shark antigen~|~shot (injury)~|~shot dosing unit~|~thermoacoustic computed tomography~|~this (eukaryote)~|~well~|~well marginated nodule~|~acute~|~acute inpatient encounter~|~aspartate-prephenate aminotransferase activity~|~glutamate-prephenate aminotransferase activity~|~mark - attribute~|~protein acetyltransferase activity~|~shark preparation~|~lengthened (qualifier value)~|~long~|~long variable
bad protein~|~histidine~|~shoulder~|~best1 gene~|~purchase~|~best (quality)~|~akr1b10 gene~|~auto~|~bad gene~|~bmp2k gene~|~bad~|~bicycle~|~bicycling (recreational activity)~|~brachial amyotrophic diplegia~|~entire shoulder region~|~histidine measurement~|~injury of shoulder and upper arm~|~off~|~rack~|~structure of hippocampal fissure~|~this (eukaryote)~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~hanging
vomiting~|~in addition to~|~specific qualifier value~|~with - dosing instruction fragment~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~left lower quadrant pain~|~nadia - zebrafish~|~usual severity vomiting~|~vomiting, ctcae
not otherwise specified~|~then~|~then - dosing instruction fragment
psychomotor agitation~|~restlessness~|~alcohol consumption~|~andorra~|~disease~|~abnormality~|~agitation~|~and~|~and - dosing instruction fragment~|~capability~|~relationshipconjunction - and~|~restlessness, ctcae~|~specific qualifier value~|~substance~|~competition~|~active~|~active control~|~active license~|~active state~|~active study~|~active brand of pseudoephedrine-triprolidine~|~concept status - active~|~document storage - active~|~document storage status - active~|~editstatus - active~|~entity status - active~|~immunization registry status - active~|~managed participation status - active~|~role status - active~|~active (hl7 rolelink)
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~bcr protein, human~|~disease~|~hemorrhage~|~not otherwise specified~|~membrane~|~all~|~bcr gene~|~bcr wt allele~|~indication of (contextual qualifier)~|~live - specimen condition~|~membrane device~|~performer (entertainment)~|~reside~|~tissue membrane~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules
helium~|~canis familiaris~|~andorra~|~intestines~|~time~|~and~|~and - dosing instruction fragment~|~case (situation)~|~case unit dose~|~clinical study case~|~dog antigen~|~dog family~|~howling~|~member organization~|~not otherwise specified~|~packaging case~|~reaching~|~relationshipconjunction - and~|~role class - member~|~tennis (activity)~|~true case status~|~usually need help from another person for reach~|~member~|~cytip gene~|~data types - time~|~time (foundation metadata concept)~|~value type - time
hospice care~|~diabetes mellitus~|~cell respiration~|~hyperkalemia~|~andorra~|~disease~|~plant leaves~|~respiration~|~membrane~|~and~|~and - dosing instruction fragment~|~approximate~|~concept generality - leaf~|~craig alaska indian~|~fighting~|~hyperkalemia, ctcae~|~insulation device~|~membrane device~|~relationshipconjunction - and~|~this (eukaryote)~|~tissue membrane~|~without~|~hospice environment~|~respiratory gaseous exchange in organisms~|~fine - adjective~|~legal fine
hospice care~|~headache~|~canada~|~hyperglycemia~|~india~|~nup214 protein, human~|~best1 gene~|~crouzon syndrome with acanthosis nigricans (disorder)~|~can - object~|~can dosing unit~|~chance~|~chronic rejection of renal transplant~|~gdc ajcc clinical n terminology~|~glucose in blood specimen above reference range~|~home environment~|~house (environment)~|~hyperglycemia, ctcae~|~india - zebrafish~|~nup214 gene~|~nup214 wt allele~|~not otherwise specified~|~purchase~|~web site~|~best (quality)~|~hospice environment
dehydration~|~vomiting~|~this (eukaryote)~|~address type - office~|~dehydration procedure~|~dehydration, ctcae~|~fighting~|~hypertension, ctcae~|~hypertensive disease~|~office~|~organization unit type - office~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~north~|~usual severity vomiting~|~vomiting, ctcae
dehydration~|~diabetes mellitus~|~italy~|~best1 gene~|~dehydration procedure~|~dehydration, ctcae~|~fighting~|~not otherwise specified~|~off~|~purchase~|~samia~|~this (eukaryote)~|~best (quality)~|~1/3 meter (distance vision finding)~|~father (person)~|~father - courtesy title~|~indirect exposure mechanism - father~|~intrathecal route of drug administration~|~near~|~relationship - father
transient ischemic attack~|~range of motion, articular~|~communicable diseases~|~congenital abnormality~|~adverse event associated with infection~|~infection~|~mobility ability~|~mobility as a finding~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~qualitative mobility~|~specific qualifier value~|~teratologic
tachycardia~|~united arab emirates~|~best1 gene~|~nr4a2 gene~|~negation~|~purchase~|~best (quality)~|~amended~|~androgen response element~|~are unit of measure~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
speech~|~vascular diseases~|~alteration~|~obama~|~three~|~three (answer to question)
toes~|~fingers~|~cell respiration~|~hand~|~andorra~|~respiration~|~respiration disorders~|~and~|~and - dosing instruction fragment~|~best1 gene~|~data table~|~entire hand~|~fingers, unit of measurement~|~off~|~purchase~|~relationshipconjunction - and~|~respiratory tract diseases~|~side~|~table - furniture~|~best (quality)~|~hand - unit of measure~|~put - instruction imperative~|~respiratory gaseous exchange in organisms
andorra~|~and~|~and - dosing instruction fragment~|~not otherwise specified~|~relationshipconjunction - and~|~motion~|~butting~|~cdisc sdtm size terminology~|~size~|~size - solid dosage form~|~update - problem/goal action code~|~update~|~update - action code~|~update - dataoperation~|~update - segment action code
dyspnea~|~nausea~|~chronic obstructive airway disease~|~best1 gene~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~purchase~|~usual severity nausea~|~best (quality)
not otherwise specified
pain~|~dyspnea~|~electricity~|~austin~|~address type - office~|~behavioral change~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~electrical (qualifier value)~|~generalized~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~mental status change~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~office~|~organization unit type - office~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specific qualifier value~|~usual severity shortness of breath~|~administration method - pain~|~adverse event associated with pain~|~extrinsic~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~pay
drug packaging~|~athletics~|~andorra~|~united arab emirates~|~epilepsy~|~syndrome~|~not otherwise specified~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~adverse event associated with syndromes~|~androgen response element~|~best1 gene~|~computer program package~|~conscious~|~consciousness related finding~|~dyrk3 gene~|~give - dosing instruction imperative~|~human cells, tissues, and cellular and tissue-based products packing~|~ik gene~|~microcephaly, epilepsy, and diabetes syndrome~|~medications~|~package~|~package dosing unit~|~radiological exposure device~|~red color~|~redness~|~roof physical object~|~side~|~taverns~|~team~|~very~|~very much~|~are unit of measure~|~best (quality)~|~comprehensive score for financial toxicity~|~cost aspects~|~financial cost~|~general medical service~|~generalized~|~safety reporting documentation~|~united states military commissioned officer o10
hyperglycemia~|~range of motion, articular~|~world health organization~|~andorra~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~congenital abnormality~|~and~|~and - dosing instruction fragment~|~mobility ability~|~mobility as a finding~|~qualitative mobility~|~relationshipconjunction - and~|~side~|~this (eukaryote)~|~teratologic~|~who temperature/humidity storage condition
signs and symptoms~|~best1 gene~|~hypertension, ctcae~|~hypertensive disease~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~reaching~|~usually need help from another person for reach~|~best (quality)~|~general symptom
disease~|~membrane~|~approximate~|~membrane device~|~teasing~|~tissue membrane
pain~|~hospice care~|~dyspnea~|~accelerated angina~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~decision~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~not otherwise specified~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~side~|~usual severity shortness of breath~|~hospice environment~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
bad protein~|~andorra~|~toes~|~fingers~|~shoulder~|~and~|~and - dosing instruction fragment~|~best1 gene~|~purchase~|~relationshipconjunction - and~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~best (quality)~|~appearance~|~bad gene~|~bad~|~brachial amyotrophic diplegia~|~entire shoulder region~|~fingers, unit of measurement~|~in addition to~|~nr4a2 gene~|~negation~|~this (eukaryote)~|~with - dosing instruction fragment~|~hanging
nausea~|~at 10~|~vomiting~|~academic research enhancement awards~|~area~|~best1 gene~|~bothered by nausea~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~decision~|~feel nausea~|~geographic locations~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~purchase~|~usual severity nausea~|~best (quality)~|~blood products laboratory testing~|~bothered by vomiting~|~extrinsic~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing~|~tests (qualifier value)~|~usual severity vomiting~|~vomiting, ctcae
vision~|~canis familiaris~|~disease~|~organism~|~membrane~|~address type - office~|~align~|~dog antigen~|~dog family~|~except for~|~howling~|~member organization~|~membrane device~|~office~|~organization unit type - office~|~other than~|~outlet (position)~|~outlet device~|~role class - member~|~see~|~tissue membrane~|~member~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
pain~|~hhip protein, human~|~rpl29 protein, human~|~st13 protein, human~|~dental occlusion~|~humulus lupulus~|~st13 wt allele~|~structure of habenulopeduncular tract~|~bone structure of ischium~|~hhip gene~|~hhip wt allele~|~hip structure~|~reg3a gene~|~reg3a wt allele~|~rpl29 gene~|~rpl29 wt allele~|~st13 gene~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~heme iron polypeptide~|~address type - office~|~best1 gene~|~during~|~during - dosing instruction fragment~|~guide device~|~hopx gene~|~hop (substance)~|~office~|~organization unit type - office~|~professional guide~|~rack~|~stip1 gene~|~stip1 wt allele~|~specific qualifier value~|~best (quality)~|~cisplatin/ifosfamide/vincristine protocol~|~doxorubicin/prednisone/vincristine protocol~|~administration method - pain~|~adverse event associated with pain~|~bite (event)~|~cep70 gene~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~specimen source codes - bite~|~usual severity pain~|~bite injury
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~bcr protein, human~|~advice~|~all~|~bcr gene~|~bcr wt allele~|~best1 gene~|~french fries~|~not otherwise specified~|~potato chips~|~purchase~|~since~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~altretamine/cisplatin/cyclophosphamide/misonidazole protocol~|~best (quality)~|~fine - adjective~|~legal fine~|~thinking, function